NCT00291109View on ClinicalTrials.gov

An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

July 31, 2005

Conditions
Breast Cancer
Interventions
DRUG

letrozole 2.5 mg

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas

OTHER

NCT00291109 - An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg | Biotech Hunter | Biotech Hunter